We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$991M
AUM Growth
+$260M
Cap. Flow
+$254M
Cap. Flow %
25.68%
Top 10 Hldgs %
35.1%
Holding
398
New
299
Increased
7
Reduced
3
Closed
88

Top Buys

Rank Stock Value
1
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$27.1M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$17.5M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$17M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$16.3M
5
IMVT icon
Immunovant
IMVT
+$12.8M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$17.7M
2
GPRE icon
Green Plains
GPRE
+$14.3M
3
NMCI
Navios Maritime Containers L.P. Common Units
NMCI
+$12.7M
4
SCOAU
ScION Tech Growth I Unit
SCOAU
+$11.5M
5
CND.U
Concord Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
CND.U
+$11.3M

Sector Composition

Rank Sector Weight
1 Financials 18.61%
2 Healthcare 10.81%
3 Technology 7.09%
4 Industrials 3.76%
5 Consumer Discretionary 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENPC
26
DELISTED
Executive Network Partnering Corporation
ENPC
$7.25M 0.73%
+745,797
New +$7.48M
FOXO
27
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$7.17M 0.72%
+3,715
New +$7.36M
LGF.B
28
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$7.05M 0.71%
+546,329
New +$7.19M
ASAQ
29
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$6.48M 0.65%
668,954
+299,558
+81% +$3.03M
KDMN
30
DELISTED
Kadmon Holdings, Inc.
KDMN
$6.12M 0.62%
+1,573,543
New +$7.21M
BREZ
31
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$5.85M 0.59%
+587,889
New +$6.01M
ATA
32
DELISTED
Americas Technology Acquisition Corp.
ATA
$5.69M 0.57%
+572,700
New +$5.75M
CND
33
DELISTED
Concord Acquisition Corp.
CND
$5.65M 0.57%
+577,589
New +$5.79M
KWAC
34
DELISTED
Kingswood Acquisition Corp.
KWAC
$5.59M 0.56%
+563,040
New +$5.65M
BLUE
35
DELISTED
bluebird bio
BLUE
$5.28M 0.53%
+13,524
New +$6.66M
SABS icon
36
SAB Biotherapeutics
SABS
$263M
$5.09M 0.51%
+51,838
New +$5.18M
ARBG
37
DELISTED
Aequi Acquisition Corp
ARBG
$4.86M 0.49%
+503,062
New +$5.1M
JSPR icon
38
Jasper Therapeutics
JSPR
$23.1M
$4.76M 0.48%
48,135
+7,580
+19% +$771K
NWS icon
39
News Corp Class B
NWS
$16.8B
$4.69M 0.47%
+199,746
New +$4.32M
EDTX
40
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$4.34M 0.44%
+441,994
New +$4.4M
ACKIT
41
DELISTED
Ackrell SPAC Partners I Co Subunits
ACKIT
$4.34M 0.44%
+438,856
New +$4.41M
AT
42
DELISTED
Atlantic Power Corporation
AT
$4.24M 0.43%
+1,466,420
New +$4.11M
ISPO
43
DELISTED
Inspirato
ISPO
$4.16M 0.42%
+21,027
New +$4.25M
ZSQR
44
Z Squared Inc
ZSQR
$254M
$4.06M 0.41%
+20,782
New +$4.19M
GLBLU
45
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$3.98M 0.4%
+400,000
New +$4M
GRDI
46
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$3.87M 0.39%
+402,288
New +$3.9M
OTRA
47
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
$3.8M 0.38%
381,460
+312,561
+454% +$3.19M
WORK
48
DELISTED
Slack Technologies, Inc.
WORK
$3.66M 0.37%
+90,167
New +$3.77M
BSN
49
DELISTED
Broadstone Acquisition Corp.
BSN
$3.65M 0.37%
+372,469
New +$3.76M
EAC
50
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$3.58M 0.36%
+368,794
New +$3.6M
1
2
3 4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Mangrove Partners held 398 positions worth $991M, up 36% from $731M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mangrove Partners deployed $254M of net new capital in Q1 2021, opening 299 new positions and adding to 7 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 7.8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Navios Maritime Containers L.P. Common Units, an estimated $12.7M trimmed.

  • Mangrove Partners's largest Q1 2021 buy was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q1 2021, an estimated $27.1M increase.
  • Mangrove Partners's biggest Q1 2021 reduction was Navios Maritime Containers L.P. Common Units, cutting an estimated $12.7M.
  • Mangrove Partners fully exited TG Therapeutics in Q1 2021, selling an estimated $17.7M.
  • Mangrove Partners's ten largest holdings make up 35% of its $991M portfolio in Q1 2021.
  • Mangrove Partners opened 299 new positions and closed 88 in Q1 2021.
  • Mangrove Partners's portfolio value rose 36% quarter-over-quarter to $991M.

Based on Mangrove Partners's 13F filing for Q1 2021, filed 17 May 2021.